LASSBio-1135

Non Antibodies

TRPV1 channels, TNF-α receptors

Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C

286, 3

A Blocker of TRPV1 Channels and Antagonist of TNF-α Receptors

25 mM in DMSO. Centrifuge all product preparations before use (10000 x g 5 min).

41116134

LASSBio-1135 is a TRPV1 channel and a TNF-α receptor antagonist1.

Yes

Transient receptor potential (TRP) channels are important mediators of sensory signaling with significant effect on signal transduction pathways and cellular activity. TRPV is a member of the Vanilloid subfamily of TRP channels1.LASSBio-1135, also known as CHEMBL466188, is a synthetic antagonist of TRPV1 channels and a blocker of TNF-α channels. It has an effective concentration of 0.1-100 μM and an IC50 of 588 and 642 nM for TRPV1 and TNF-α receptors respectively. LASSbio belongs to a family of imidazo[1, 2-a] pyridine derivatives and was found to be an inhibitor of p38 MAPK and COX2 in vivo. However, similar results have not been shown to this day in vitro where LASSbio failed to inhibit p38 MAPK directly and only slightly inhibited COX2. LASSbio is highly effective in completely reducing hyperalgesia induced by capsaicin and inhibits capsaicin evoked currents in a concentration dependent manner. LASSbio also inhibits TNF-α production in macrophages stimulated by LPS by reducing p38 MAPK activation through a modulation of an upstream signaling pathway thus making it a possible therapeutic agent for the prevention of neuropathic and other pain2.